T2 Biosystems
Brett Giffin has served as the Chief Commercial Officer since November 2021. He brings a wealth of industry experience and commercial leadership to T2 Biosystems, having served as Chief Executive Officer for two early-stage medical technology companies, as Chief Commercial Officer at Accriva Diagnostics (formerly ITC Medical), and in several sales and marketing leadership roles at Datascope, Covidien, Boston Scientific, and Johnson & Johnson. He began his career as a U.S. Army officer, serving in Panama and Central America.
Mr. Giffin is a Distinguished Military Graduate of the College of William & Mary and received a bachelor’s degree in Political Science from Christopher Newport University and a Master’s in Business Management from the University of Phoenix.
This person is not in any teams
This person is not in any offices
T2 Biosystems
T2 Biosystems, Inc. is an in vitro diagnostics company engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company's T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and o...